Enteroviral Cardiomyopathy: Bad News for the Dystrophin-Glycoprotein Complex

[1]  M. James,et al.  The structure of the 2A proteinase from a common cold virus: a proteinase responsible for the shut‐off of host‐cell protein synthesis , 1999, The EMBO journal.

[2]  C. Badorff,et al.  The immune system in viral myocarditis: maintaining the balance. , 1999, Circulation research.

[3]  K. Campbell,et al.  Disruption of the Sarcoglycan–Sarcospan Complex in Vascular Smooth Muscle A Novel Mechanism for Cardiomyopathy and Muscular Dystrophy , 1999, Cell.

[4]  K. Chien,et al.  Complexity in simplicity: monogenic disorders and complex cardiomyopathies. , 1999, The Journal of clinical investigation.

[5]  D. Biral,et al.  Ecto-ATPase Activity of α-Sarcoglycan (Adhalin)* , 1999, The Journal of Biological Chemistry.

[6]  M. Martone,et al.  Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy , 1999, Nature Medicine.

[7]  N. Dalton,et al.  Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. , 1998, The Journal of clinical investigation.

[8]  K. Campbell,et al.  The sarcoglycan complex in limb-girdle muscular dystrophy. , 1998, Current opinion in neurology.

[9]  B. Polla,,et al.  Effects of iron deprivation on the pathology and stress protein expression in murine X-linked muscular dystrophy. , 1998, Biochemical pharmacology.

[10]  R. Kandolf,et al.  Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. , 1998, Circulation.

[11]  S. Thibodeau,et al.  Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. , 1998, Science.

[12]  M. Bobrow,et al.  Dystrophins in vertebrates and invertebrates. , 1998, Human molecular genetics.

[13]  J. Towbin,et al.  The role of cytoskeletal proteins in cardiomyopathies. , 1998, Current opinion in cell biology.

[14]  N. Sonenberg,et al.  A Novel Functional Human Eukaryotic Translation Initiation Factor 4G , 1998, Molecular and Cellular Biology.

[15]  K. Campbell,et al.  Sarcospan, the 25-kDa Transmembrane Component of the Dystrophin-Glycoprotein Complex* , 1997, The Journal of Biological Chemistry.

[16]  J. Ervasti,et al.  Dystrophin-Glycoprotein Complex Is Monomeric and Stabilizes Actin Filaments in Vitro through a Lateral Association* , 1997, The Journal of Biological Chemistry.

[17]  J. Sanes,et al.  Skeletal and Cardiac Myopathies in Mice Lacking Utrophin and Dystrophin: A Model for Duchenne Muscular Dystrophy , 1997, Cell.

[18]  J. Tidball,et al.  Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. , 1997, The Journal of clinical investigation.

[19]  A. Beggs.  Dystrophinopathy, the expanding phenotype. Dystrophin abnormalities in X-linked dilated cardiomyopathy. , 1997, Circulation.

[20]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[21]  K. Campbell,et al.  Muscular dystrophies and the dystrophin-glycoprotein complex. , 1997, Current opinion in neurology.

[22]  Y. Hayashizaki,et al.  Identification of the Syrian hamster cardiomyopathy gene. , 1997, Human Molecular Genetics.

[23]  Minoru Hongo,et al.  MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart Failure , 1997, Cell.

[24]  W. Mckenna,et al.  Coxsackie B viruses and human heart disease. , 1997, Current topics in microbiology and immunology.

[25]  N. Blom,et al.  Cleavage site analysis in picornaviral polyproteins: Discovering cellular targets by neural networks , 1996, Protein science : a publication of the Protein Society.

[26]  J. McMurray,et al.  Heart failure – implications of the true size of the problem , 1996, Journal of internal medicine.

[27]  H. Schultheiss,et al.  The role of the ADP/ATP carrier in the pathogenesis of viral heart disease. , 1995, European heart journal.

[28]  B. Strauer,et al.  [Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy]. , 1995, Zeitschrift fur Kardiologie.

[29]  F. Muntoni,et al.  Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. , 1993, The New England journal of medicine.

[30]  R. Rhoads,et al.  Mapping the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human Coxsackievirus and rhinovirus. , 1993, The Journal of biological chemistry.

[31]  P E Leaverton,et al.  Prevalence and mortality rate of congestive heart failure in the United States. , 1992, Journal of the American College of Cardiology.

[32]  K. Klingel,et al.  Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[33]  G. Lopaschuk,et al.  Viral heart disease. , 1990, Chest.

[34]  J. Ervasti,et al.  Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle , 1990, Nature.

[35]  L. Kunkel,et al.  Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. , 1990, The Journal of biological chemistry.

[36]  M. W. Thompson,et al.  Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. , 1988, Science.

[37]  A. Monaco,et al.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein , 1988, Cell.

[38]  C. Gauntt,et al.  Coxsackievirus Group B Replication in Cultured Fetal Baboon Aortic Smooth Muscle Cells , 1986, Journal of medical virology.